LifeStance Health (LFST) Revenue (2020 - 2026)

LifeStance Health (LFST) has 7 years of Revenue data on file, last reported at $403.5 million in Q1 2026.

• Revenue for Q1 2026 came in at $403.5 million, up 21.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 16.46% YoY), and the FY2025 annual result was $1.4 billion, up 13.85% from the prior year.
• Revenue improved to $403.5 million in Q1 2026 per LFST's latest filing, from $382.2 million in the prior quarter.
• Over five years, Revenue peaked at $403.5 million in Q1 2026 and troughed at $203.1 million in Q1 2022.
• A 5-year average of $293.8 million and a median of $300.4 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue soared 41.89% in 2022, then rose 10.56% in 2025.
• A 5-year view of Revenue shows it stood at $229.4 million in 2022, then climbed by 22.34% to $280.6 million in 2023, then rose by 15.99% to $325.5 million in 2024, then climbed by 17.43% to $382.2 million in 2025, then climbed by 5.57% to $403.5 million in 2026.
• Business Quant data shows LFST's Revenue at $403.5 million in Q1 2026, $382.2 million in Q4 2025, and $363.8 million in Q3 2025.